Phosphorylated Epidermal Growth Factor Receptor on Tumor-Associated Endothelial Cells in Human Renal Cell Carcinoma Is a Primary Target for Therapy by Tyrosine Kinase Inhibitors

Benzer Materyaller

• Phosphorylated Epidermal Growth Factor Receptor on Tumor-Associated Endothelial Cells Is a Primary Target for Therapy with Tyrosine Kinase Inhibitors
  Yazar:: Kuwai, Toshio, ve diğerleri
  Baskı/Yayın Bilgisi: (2008)
• Complete remission with tyrosine kinase inhibitors in renal cell carcinoma
  Yazar:: Wada, Yoshihiro, ve diğerleri
  Baskı/Yayın Bilgisi: (2012)
• Tyrosine kinase inhibitors and immunotherapy combinations in renal cell carcinoma
  Yazar:: Rassy, Elie, ve diğerleri
  Baskı/Yayın Bilgisi: (2020)
• Blockade of Epidermal Growth Factor Receptor Signaling on Tumor Cells and Tumor-Associated Endothelial Cells for Therapy of Human Carcinomas
  Yazar:: Baker, Cheryl H., ve diğerleri
  Baskı/Yayın Bilgisi: (2002)
• Tyrosine Kinase Inhibitors in the Treatment of Advanced Renal Cell Carcinoma: Focus on Pazopanib
  Yazar:: Vasudev, Naveen S., ve diğerleri
  Baskı/Yayın Bilgisi: (2011)